Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1789-1795

  Clunn, G F ^a   Lymn, J S ^a   Schachter, M ^a   Hughes, A D ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Angiotensin II; Calcium homeostasis; Lovastatin; Platelet derived growth factor; Tyrosine phosphorylation; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; CALCIUM ION; CHOLESTEROL; FURA 2; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENOID; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PERTUSSIS TOXIN; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL SUSPENSION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ISOPRENYLATION; MUSCLE FIBER CULTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CALCIUM; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MALE; MITOGENS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 0030760916     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701299     Document Type: Article

References (54)

1. ABEDI, H., DAWES, K.E. & ZACHARY, I. (1995). Differential effects of platelet-derived growth factor-BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol. Chem., 270, 11367-11376.
2. BERRIDGE, M.J. (1993). Inositol trisphosphate and calcium signalling. Nature, 361, 315-325.
3. BOCHOV, V., TKACHUK, V., BUHLER, F. & RESINK, T. (1992). Phosphoinositide and calcium signalling responses in smooth muscle cells: comparison between lipoproteins, Ang II and PDGF. Biochem. Biophys. Res. Commun., 188, 1295-1305.
4. BOURNE, H.R., SANDERS, D.A. & MCCORMICK, F. (1990). The GTPase superfamily: a conserved switch for diverse cell functions. Nature, 348, 125-132.
5. BRUNS, C. & MARME, D. (1987). Pertussis toxin inhibits the angiotensin II and serotonin-induced rise of cytoplasmic calcium in cultured smooth muscle cells from rat aorta. FEBS Lett., 212, 40-44.
6. CASEY, P. (1994). Lipid modifications of G proteins. Curr. Opin. Cell Biol., 6, 219-225.
7. CASEY, P.J. (1995). Protein lipidation in cell signaling. Science, 268, 221-225.
8. 1 cells. FEBS Lett., 361, 46-50.
9. CHONG, L.D., TRAYNOR-KAPLAN, A., BOKOCH, G.M. & SCHWARTZ, M.A. (1994). The small GTP-binding protein rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell, 79, 507-513.
10. CLARKE, S. (1992). Protein isoprenylation and methylation at carboxyl terminal cysteine residues. Annu. Rev. Biochem., 61, 355-386.
11. CLAESSON-WELSH, L. (1994). Platelet-derived growth factor receptor signals. J. Biol. Chem., 269, 32023-32026.
12. CORSINI, A., MAZZOTTI, M., RAITERI, M., SOMA, M.R., GABBIANI, G., FUMAGALLI, R. & PAOLETTI, R. (1993). Relationship between mevalonate pathway and arterial myocyte proliferation: in vivo studies with inhibitors of HMG-CoA reductase. Atherosclerosis, 101, 117-125.
13. DOSTAL, D.E., MURAHASHI, T. & PEACH, M.J. (1990). Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension, 15, 815-822.
14. ENDO, A. (1992). The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res., 33, 1569-1582.
15. ESCOBEDO, J.A. & WILLIAMS, L.T. (1988). A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature, 335, 85-87.
16. ESTACION, M. & MORDEN, M.J. (1993). Expression of voltage gated calcium channels correlates with PDGF stimulated calcium influx and depends upon cell density in C3H 10T1/2 mouse fibroblasts. Cell Calcium, 14, 161-171.
17. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. Sci., 15, 77-83.
18. FRACE, A.M. & GARGUS, J.J. (1989). Activation of single-channel currents in mouse fibroblasts by platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A., 86, 2511-2515.
19. GLOMSET, J.A., GELB, M.H. & FARNSWORTH, C.C. (1990). Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem. Sci., 15, 139-142.
20. GOLDSTEIN, J.L. & BROWN, M.S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425-430.
21. 2+ indicators with improved fluorescence properties. J. Biol. Chem., 260, 3340-3350.
22. 2. J. Biol. Chem., 265, 14784-14790.
23. HANCOCK, J.F., MAGEE, A.I., CHILDS, J.E. & MARSHALL, C.J. (1989). All ras proteins are polisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177.
24. HOLLENBERG, M.D. (1994). Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci., 15, 108-114.
25. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br. J. Pharmacol., 114, 138-142.
26. HUGHES, A.D. (1995b). Calcium channels in vascular smooth muscle cells. J. Vasc. Res., 32, 353-370.
27. HUGHES, A.D. (1996). The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering. J. Hum. Hypertens., 10, 387-390.
28. HUGHES, A.D., CLUNN, G.F. & SCHACHTER, M. (1994). Low density lipoprotein and calcium homeostasis in human vascular smooth muscle cells. Biochem. Soc. Trans., 22, S145.
29. HUGHES, A.D., PATEL, M., WIJETUNGE, S., CLUNN, G. & SCHACHTER, M. (1995). Comparison of the effects of platelet-derived growth factor (PDGF) isoforms on signalling and S-phase entry of human cultured saphenous vein cells. J. Cardiovasc. Pharmacol., 25, 481-485.
30. IRANI, K., HERZLINGER, S. & FINKEL, T. (1994). Ras proteins regulate multiple mitogenic pathways in AlO vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 202, 1252-1258.
31. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. J. Bio. Chem., 269, 9011-9018.
32. LEBOWITZ, P.F., DAVIDE, J.P. & PRENDERGAST, G.C. (1995). Evidence that farnesyltransferase inhibitors suppress ras transformation by interfering with rho activity. Mol. Cell Biol., 15, 6613-6622.
33. MA, H.P., MATSUNAGA, H., LI, B., SCHIEFFER, B., MARRERO, M.B. & LING, B.N. (1996). Calcium channel activation by platelet-derived growth factor induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells. J. Clin. Invest., 97, 2332-2341.
34. MALTESE, W.A. (1990). Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J., 4, 3319-3328.
35. MARRERO, M.B., PAXTON, W.G., DUFF, J.L., BERK, B.C. & BERNSTEIN, K.E. (1994). Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γl in vascular smooth muscle cells. J. Biol. Chem., 269, 10935-10939.
36. MEISENHELDER, J., SUH, P-G., RHEE, S.G. & HUNTER, T. (1989). Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell, 57, 1109-1122.
37. MOGAMI, H. & KOJIMA, I. (1993). Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 196, 650-658.
38. MUNRO, E., PATEL, M., CHAN, P., BETTERIDGE, L., CLUNN, G., GALLAGHER, K., HUGHES, A., SCHACHTER, M., WOLFE, J. & SEVER, P. (1994). Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis. Eur. J. Clin. Invest., 24, 766-772.
39. NAKAO, J., HIDEKI, I., OOYAMA, T., CHANG, W-C., & MUROTA, S. (1983). Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetanoic acid: Effects of A23187, nicardipine, and trifluoperazine. Atherosclerosis, 46, 309-319.
40. 2+ responses in rat A10 vascular smooth muscle cells. Circ. Res., 74, 173-181.
41. 2+ concentrations. Biochem. Biophys. Res. Commun., 188, 1198-1204.
42. NOMOTO, A., MUTH, S., HAGIHARA, H. & YAMAGUCHI, I. (1988). Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist nivaldipine. Atherosclerosis, 72, 213-223.
43. OHYA, Y. & SPERELAKIS, N. (1991). Involvement of a GTP-binding protein in stimulating action of angiotensin II on calcium channels in vascular smooth muscle cells. Circ. Res., 68, 763-771.
44. PATEL, M.K., BETTERIDGE, L.J., HUGHES, A.D., CLUNN, G.F., SCHACHTER, M., SHAW, R.J. & SEVER, P.S. (1996). Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J. Hypertens., 14, 341-347.
45. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem. Biophys. Res. Commun., 200, 260-267.
46. SATOH, T., FANTL, W.J., ESCOBEDO, J.A., WILLIAMS, L.T. & KAZIRO. Y. (1993). Platelet-derived growth factor receptor mediates activation of Ras through different signalling pathways in different cell types. Mol. Cell Biol., 13, 3706-3713.
47. SKALLI, O., VANDERKERCKHOVE, J. & GABBIANI, G. (1987). Actin isoform pattern as a marker of normal or pathological smooth muscle and fibroblastic tissues. Differentiation, 33, 232-238.
48. SZOLLOSI, J., FEUERSTEIN, B.G., VEREB, G., PERSHADSINGH, H.A. & MARTON, L.J. (1991). Calcium channels in PDGF stimulated A172 cells open after intracellular release and are not voltage dependent. Cell Calcium, 12, 477-491.
49. H p21 proteins of EJ bladder carcinoma and its normal cellular and viral homologs. Mol. Cell. Biol., 4, 1647-1652.
50. WATKINS, D.C., NORTHUP, J.K. & MALBON, C.C. (1987). Regulation of G-proteins in differentiation. Altered ratio of alpha to beta subunits in 3T3-L1 cells. J. Biol. Chem., 262, 10651-10657.
51. WIJETUNGE, S. & HUGHES, A.D. (1995). Effect of platelet-derived growth factor on voltage-operated calcium channels in isolated rabbit ear artery cells. Br. J. Pharmacol., 114, 534-538.
52. XUAN, Y.T., SU, Y.F., CHANG, K.J. & WATKINS, W.D. (1987). A pertussis/cholera toxin sensitive G protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cells. Biochem. Biophys. Res. Commun., 146, 898-906.
53. ZENG, Y.Y., BENISHIN, C.G. & PANG, P.K. (1989). Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride. J. Pharmacol. Exp. Ther., 250, 343-351.
54. ZUBIAUR, M., SANCHO, J., TERHORST, C. & FALLER, D. V. (1995). A Small GTP-binding protein, rho, associates with the platelet-derived growth factor type-beta receptor upon ligand binding J Biol. Chem., 270, 17221-17228.